GLYCOSYLATED PROTEOLIPOSOMES--A NEW DELIVERY VEHICLE
GLYCOSYLATED PROTEOLIPOSOMES--A NEW DELIVERY VEHICLE
批准号:
3431903
负责人:
ANTHONY W SCOTTO
金额:
$5.41万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-07-15 至 1993-07-14
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of this proposal is to examine the concept of the
proteoliposome as an alternative to the liposome as a in vivo vehicle.
The recent discovery of the spontaneous incorporation of integral
membrane proteins into preformed unilamellar vesicles to form
proteoliposomes allows, for the first time, the consideration of the
proteoliposome as a feasible and economical alternative to the liposome
for in vivo applications. The insertion of glycosylated integral
membrane proteins derived from erythrocyte membranes, sialoglyco- and
glyco-proteins, results in a stable modification of the surface of the
vesicles potentially superior to that provided by the inclusion of
glycolipids in liposomes; we hypothesize that the glycocalyx of these
proteoliposomes can be "tailored" to result in a more persistent in vivo
vehicle than that possible with a liposome composed of only lipids. It
has already been shown that the proteoliposome is more stable in solution
than similar liposomes; the initial aims of this study will be directed
towards as examination of the relative stability of the proteoliposome
versus the liposome with the components of blood. Subsequently, we will
examine the intravascular persistence of various constructs of
glycosylated proteoliposomes and determine whether the glycosylated
proteoliposome can serve as a model for future drug delivery or
hemoglobin carrier vehicles. The current aims are designed to test this
concept in the most simple approach by using proteoliposomes prepared
from erythrocyte integral membrane proteins derived from the same species
as the recipient of the proteoliposome infusion (New Zealand rabbits),
thereby avoiding most immunological complications. However, the
long-term goal of this research is to construct an immunologically safe
proteoliposome by synthesizing the simplest glycosylated hydrophobic
(peptide) protein anchor required to provide a stable glycocalyx on the
liposome by genetic engineering and/or organic synthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic Targeting of the Infectious Path of Anthrax
-
批准号:6634356
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2003
-
负责人:ANTHONY W SCOTTO
-
依托单位:
THE PROTEOLIPOSOME: A MEMBRANE MODEL
-
批准号:3304298
-
项目类别:
-
资助金额:$18.59万
-
财政年份:1990
-
负责人:ANTHONY W SCOTTO
-
依托单位:
PROTEOLIPOSOME--A MEMBRANE MODEL
-
批准号:3304297
-
项目类别:
-
资助金额:$16.88万
-
财政年份:1990
-
负责人:ANTHONY W SCOTTO
-
依托单位:
PROTEOLIPOSOME--MEMBRANE MODEL
-
批准号:3304296
-
项目类别:
-
资助金额:$16.26万
-
财政年份:1990
-
负责人:ANTHONY W SCOTTO
-
依托单位:
PROTEOLIPOSOME--A MEMBRANE MODEL
-
批准号:2182885
-
项目类别:
-
资助金额:$19.29万
-
财政年份:1990
-
负责人:ANTHONY W SCOTTO
-
依托单位:
PROTEOLIPOSOME--MEMBRANE MODEL
-
批准号:3304295
-
项目类别:
-
资助金额:$16.74万
-
财政年份:1990
-
负责人:ANTHONY W SCOTTO
-
依托单位:
MEMBRANE BIOGENESIS AND MEMBRANE FUSION
-
批准号:3291043
-
项目类别:
-
资助金额:$8.99万
-
财政年份:1986
-
负责人:ANTHONY W SCOTTO
-
依托单位:
MEMBRANE BIOGENESIS AND MEMBRANE FUSION
-
批准号:3291042
-
项目类别:
-
资助金额:$9.41万
-
财政年份:1986
-
负责人:ANTHONY W SCOTTO
-
依托单位:
MEMBRANE BIOGENESIS AND MEMBRANE FUSION
-
批准号:3291040
-
项目类别:
-
资助金额:$11.22万
-
财政年份:1986
-
负责人:ANTHONY W SCOTTO
-
依托单位:
海外基金